4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Cell Transformation, Neoplastic in 1 studies
4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armanious, H | 1 |
| Gelebart, P | 1 |
| Anand, M | 1 |
| Lai, R | 1 |
1 other study available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Identification of a novel crosstalk between casein kinase 2α and NPM-ALK in ALK-positive anaplastic large cell lymphoma.
Topics: beta Catenin; Casein Kinase II; Cell Communication; Cell Line, Tumor; Cell Proliferation; Cell Trans | 2013 |